Feedback
Make this your Home
CNBC-TV18 Markets Mutual Funds IPO Commodities Wealth Portfolio Messages Specials Videos Mail
CNBC-TV18 Matrix SENSEX 16498.72 340.44 NIFTY 4898.40 102.25

Aurobindo Pharma

BSE: 524804  |  NSE: AUROPHARMA  |  ISIN: INE406A01029  |  Pharmaceuticals
    
 

Have a tip or information to share on Aurobindo Pharma?


Message   Positive opinion   Negative opinion   Query   Grievance   
View by : 
Latest Messages   |   Most Active   |   Top Rated   |   Top Tracked   |   Active Boarders
Go to page:   1    2    3    4    5    6    Next  [  ]    
Sort by:   
Positive Opinions   |   Negative Opinions   |   Queries   |   Grievances   |   ALL
09 Nov 2009 16:26

NSE Announcements on Aurobindo Pharm

Posted by : MMB Messenger
Price when posted : [Aurobindo Pharm - BSE:Rs. 819.30 NSE:Rs. 135.65 when posted]

Aurobindo Pharma Ltd has informed the Exchange regarding a press release dated November 09, 2009, titled "Aurobindo Pharma receives final approval for Cefotaxime for Injection USP". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). ...

09 Nov 2009 15:58

BSE Announcements on Aurobindo Pharm

Posted by : MMB Messenger
Price when posted : [Aurobindo Pharm - BSE:Rs. 819.30 NSE:Rs. 135.65 when posted]

Aurobindo Pharma Ltd has informed BSE regarding a Press Release dated November 09, 2009 titled "Aurobindo Pharma receives final approval for Cefotaxime for Injection USP"...

09 Nov 2009 15:28

Aurobindo Pharma receives final USFDA approval

Posted by : pms.swastika
Price when posted : BSE: Rs 817.00 ( 0.05 % ), NSE: Rs. 820.15 ( 0.21 % )

Aurobindo Pharma receives final USFDA approval

Aurobindo Pharma receives final USFDA approval for its 2 new Injections.

Regards
Swastika PMS...

06 Nov 2009 12:42

Aurobindo Pharma receives approval

Posted by : PUNTER
Price when posted : BSE: Rs 822.20 ( 1.72 % ), NSE: Rs. 818.00 ( 1.43 % )

The number of USFDA approvals is steadily increasing in its kitty. Aurobindo is definitely a multi-bagger. Buy and hold....

06 Nov 2009 12:19

NSE Announcements on Aurobindo Pharm

Posted by : MMB Messenger
Price when posted : [Aurobindo Pharm - BSE:Rs. 825.50 NSE:Rs. 170.70 when posted]

Aurobindo Pharma Ltd has informed the Exchange regarding a press release dated November 06, 2009, titled "Aurobindo Pharma receives final approval for Lamotrigine Tablets from USFDA". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). ...

06 Nov 2009 11:07

Aurobindo Pharma receives approval

Posted by : pms.swastika
Price when posted : BSE: Rs 834.20 ( 3.20 % ), NSE: Rs. 835.50 ( 3.60 % )

Aurobindo Pharma receives approval

Aurobindo Pharma receives final approval for "Lamotrigine" tablets from USFDA.

Regards
Swastika PMS...

04 Nov 2009 17:59

Auro near term target=900....

Posted by : marketman
Price when posted : BSE: Rs 793.75 ( 5.79 % ), NSE: Rs. 793.95 ( 5.68 % )

The scrip is looking very strong.......

04 Nov 2009 13:21

BSE Announcements on Aurobindo Pharm

Posted by : MMB Messenger
Price when posted : [Aurobindo Pharm - BSE:Rs. 774.50 NSE:Rs. 135.65 when posted]

Aurobindo Pharma Ltd has informed BSE that in terms of the issue of USD 60 Million Convertible Bonds due 2010, the Bonds are convertible at any time on or after September 20, 2005 up to August 01, 2010 by the holders of the Bonds into Equity Shares of Rs. 5/- each of the Company at a conversion price of Rs. 522.036 per share with a fixed rate of exchange on conversion at Rs. 43.3925 per US $ 1.

Accordingly, pursuant to the applications received for conversion from one of the Bondholders, the Committee of the Board of Directors of the Company at its meeting held on November 04, 2009 has considered the request and allotted 83,121 Equity Shares of Rs. 5/- each for cash at a premium of Rs. 517.036 by conversion of Bonds worth USD 1,000,000 in terms of the offer document to the FCCB holders.

Consequent to the aforesaid allotment the paid up capital of the Company has gone up from 53,765,268 Equity Shares of Rs. 5/- each to 53,848,389 Equity Shares of Rs. 5/- each....

04 Nov 2009 13:19

NSE Announcements on Aurobindo Pharm

Posted by : MMB Messenger
Price when posted : [Aurobindo Pharm - BSE:Rs. 774.50 NSE:Rs. 135.65 when posted]

Aurobindo Pharma Ltd has informed the Exchange that "In terms of the issue, the Bonds are convertible at any time on or after 20th September 2005 up to 1st August 2010 by the holders of the Bonds into Equity Shares of Rs.5/- each of the Company at a conversion price of Rs.522.036 per share with a fixed rate of exchange on conversion at Rs.43.3925 per US $ 1. Accordingly, pursuant to the application received for conversion from one of the Bondholders, the Committee of the Board of Directors of the Company at its meeting held on 04.11.2009 has considered the request and allotted 83,121 Equity Shares of Rs.5/- each for cash at a premium of Rs.517.036 by conversion of Bonds worth USD 1,000,000 in terms of the offer document to the FCCB holders. Consequent to the aforesaid allotment the paid up capital of the Company has gone up from 53,765,268 Equity Shares of Rs.5/- each to 53,848,389 Equity Shares of Rs.5/- each"....

03 Nov 2009 10:43

Auro near term target=900....

Posted by : marketman
Price when posted : BSE: Rs 760.75 ( 1.53 % ), NSE: Rs. 760.00 ( 1.23 % )

Investors can hold the stockupto 900 till the next results.......

02 Nov 2009 16:11

Auro near term target=900....

Posted by : ambrishkapoor
Price when posted : BSE: Rs 749.25 ( -3.38 % ), NSE: Rs. 750.80 ( -2.68 % )

Its consolidated net profit was at Rs 103.1 crore versus net loss of Rs 38.4 crore (moneycontrol and bse).
Excellent results can take it beyond 900 too. Lets c how it behaves on tuesday....

31 Oct 2009 12:31

BSE Announcements on Aurobindo Pharm

Posted by : MMB Messenger
Price when posted : [Aurobindo Pharm - BSE:Rs. 749.25 NSE:Rs. 135.65 when posted]

Aurobindo Pharma Ltd has informed BSE regarding a Press Release dated October 30, 2009 titled "Aurobindo Pharma Q2 2009-10 Unaudited Results". ...

30 Oct 2009 19:32

BSE Announcements on Aurobindo Pharm

Posted by : MMB Messenger
Price when posted : [Aurobindo Pharm - BSE:Rs. 749.25 NSE:Rs. 170.70 when posted]

Aurobindo Pharma Ltd has informed BSE that Dr. D. Rajagopala Reddy has been appointed as an Additional Director of the Company at the Boar Meeting held on October 30, 2009. He will function as a Non Executive and Independent Director of the Company.

Dr. S. Bimal Singh a Non Executive and Independent Director of the Company has resigned from the Board of the Company w.e.f. October 30, 2009.
...

30 Oct 2009 18:08

BSE Announcements on Aurobindo Pharm

Posted by : MMB Messenger
Price when posted : [Aurobindo Pharm - BSE:Rs. 749.25 NSE:Rs. 135.65 when posted]

Aurobindo Pharma Ltd has informed BSE about the Financial Results for the Quarter ended September 30, 2009....

30 Oct 2009 17:55

Auro near term target=900....

Posted by : marketman
Price when posted : BSE: Rs 749.25 ( -3.38 % ), NSE: Rs. 750.80 ( -2.68 % )

The latest results are very good as expected.... full year eps could be 90 and at 10 pe multiple the scrip is said to be fairly valued at 900 for the near term.... there is nothing wrong in buying the scrip upto 900 during this year.......